In this video, Elizabeth Hexner, MD, offers a case study to illustrate the current treatments for the myeloproliferative neoplasms (MPNs), rare blood disorders that require nuanced considerations during therapy. Dr Hexner’s topics include the indications for cytoreduction in patients with polycythemia vera, the role of interferon in the MPNs, and the current and future therapies for myelofibrosis.
Published
December 7, 2016
Created by
BROADCASTMED